• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Nicolaus Kröger, Anita Badbaran, +14 authors Axel Rolf Zander
  • Medicine
  • Biology of blood and marrow transplantation…
  • 2013 (First Publication: 1 March 2013)
  • Within a prospective protocol, the incidence and impact of achievement of molecular remission (mCR) and high-risk cytogenetics was investigated in 73 patients with multiple myeloma (MM) afterContinue Reading
  • Nicolaus Kröger, Haefaa Alchalby, +8 authors Axel Rolf Zander
  • Medicine
  • Blood
  • 2009 (First Publication: 19 February 2009)
  • To the editor: Primary myelofibrosis is a myeloproliferative disease, and results of conventional treatment remain unsatisfactory.[1][1],[2][2] Allogeneic stem cell transplantation afterContinue Reading
  • Nicolaus Kröger, Anita Badbaran, +14 authors Axel Zander
  • Medicine
  • Experimental hematology
  • 2009 (First Publication: 1 July 2009)
  • OBJECTIVE To investigate post-transplant immunotherapy with escalating donor-lymphocyte infusions (DLI) and novel agents (thalidomide, bortezomib, and lenalidomide) to target complete remission (CR).Continue Reading
  • Evgeny Klyuchnikov, Jean El‐Cheikh, +15 authors Nicolaus Kröger
  • Medicine
  • Biology of blood and marrow transplantation…
  • 2014 (First Publication: 1 March 2014)
  • We retrospectively analyzed outcomes of a CD34(+)-selected stem cell boost (SCB) without prior conditioning in 32 patients (male/22; median age of 54 years; range, 20 to 69) with poor graft function,Continue Reading
  • Evgeny Klyuchnikov, Ulrike Bacher, +23 authors Mehdi Hamadani
  • Medicine
  • Bone Marrow Transplantation
  • 2016 (First Publication: 27 August 2015)
  • Grade 3 follicular lymphoma (FL) has aggressive clinical behavior. To evaluate the optimal first transplantation approach in relapsed/refractory grade 3 FL patients, we compared the long-termContinue Reading
  • Tanja Stahl, Anita Badbaran, +12 authors Ulrike Bacher
  • Medicine
  • Leukemia & lymphoma
  • 2010 (First Publication: 1 October 2010)
  • Considering the high relapse rates of AML after allogeneic hematopoietic stem cell transplant, research aims to improve post-transplant surveillance. To determine the value of peripheral blood (PB)Continue Reading
  • Evgeny Klyuchnikov, Svetlana Asenova, +9 authors Ulrike Bacher
  • Medicine
  • Leukemia & lymphoma
  • 2010 (First Publication: 1 August 2010)
  • We evaluated immune recovery in 67 patients with acute myeloid leukemia (AML) with a median age of 40 years (4–69) following allo-SCT after reduced (n = 35) or myeloablative (n = 32) conditioning.Continue Reading
  • Evgeny Klyuchnikov, Ulrike Bacher, +28 authors Mehdi Hamadani
  • Medicine
  • Biology of blood and marrow transplantation…
  • 2015 (First Publication: 1 December 2015)
  • This study was conducted to compare long-term outcomes in patients with refractory/relapsed grades 1 and 2 follicular lymphoma (FL) after allogeneic (allo) versus autologous (auto) hematopoietic cellContinue Reading